Link: https://discuss.online/api/v3/image_proxy?url=https%3A%2F%2Fimg.youtube.com%2Fvi%2FnSs35V6UJH8%2Fmaxresdefault.jpg

Dr Andrew McIntyre is a Gastroenterologist and Hepatologist who graduated and gained his qualifications in 1990 from Queensland University. He opened the doors to Buderim Gastroenterology in 1997. Dr. McIntyre has extensive experience in all aspects of Gastroenterology with a special interest in ERCP and associated Therapeutic Intervention.

https://youtu.be/nSs35V6UJH8

:::spoiler summerizer

• Clinical framing

  • Most clinical workload is tied to insulin resistance (~90%).
  • Pancreatic cancer and bowel cancer patients are virtually all insulin resistant in clinical experience; surgical pathways limit longitudinal dietary intervention.
  • Low-carbohydrate diets are used for over a decade and are the default diet for fatty liver.

• Metabolism and respiratory quotient

  • Human energy production is food oxidation to CO2, water, and energy; plant photosynthesis fixes CO2 into sugar using solar energy.
  • Ruminant digestion converts plant sugar to fat; CO2 release is CO2 previously fixed by plants.
  • A full ketogenic diet has an RQ ~0.7; pure carbohydrate oxidation has an RQ ~1.0; lower RQ corresponds to lower CO2 emitted per oxygen consumed.
  • Overnight fat oxidation maintains energy; sugar dependence produces overnight “running out of sugar” with sleep disturbance.
  • Morning triglycerides are low after overnight fat oxidation; high triglycerides point to insulin resistance.

• Gastroenterology-relevant applications

  • Fatty liver is common (~30% of the adult population) and responds to low-carbohydrate approaches.
  • Reflux is an early sign of metabolic dysfunction and improves with low-carbohydrate diets.
  • Irritable bowel symptoms improve with low-carbohydrate diets.
  • Ulcerative colitis and Crohn’s disease show improved symptom control as an adjunct; full remission not observed in described cases.
  • Constipation improves with low-fiber or zero-fiber diets in many cases; adequate fat intake is central; some individuals respond to adding some fiber.

• Fatty liver study example and mechanistic claims

  • A 10-patient intervention in significant fatty liver used <30 g/day carbohydrate for 2 weeks with attempted weight-stability; liver fat decreased by ~43–50% within 2 weeks.
  • Microbiome composition changed; folate-producing bacteria increased.
  • Some hepatic fat metabolism is folate dependent; increased folate production aligns with increased hepatic fat burning.
  • Liver tests normalize rapidly (example timeframe ~6 weeks).

• Guideline and evidence-process critiques

  • Slide text: “weight loss is more important than diet type”; “no macronutrient ratio makes any difference.”
  • Mediterranean diet and plant-based diets with minimal animal protein are in the guidance.
  • “Blue zones” evidence is confounded.
  • A society guideline has “diet” mentioned twice and limits detail to “diet and lifestyle,” with predominant focus on pharmacotherapy.
  • ≥50% of what is read in major journals is false, not reproducible, and corrupt; journal income streams bias results.
  • Consensus guideline-based medicine is linked with suppression of alternative views and regulatory constraints.

• Pharmacotherapy and economics

  • Semiglutamide has beneficial effects and costs about $500/month; scaling to ~30% of adults yields large public expenditure.
  • Pharmacotherapy is financially favorable for pharmaceutical companies.

• Diet composition, animal protein, and population health claims

  • Eat-Lancet per-day meat recommendations are linked to child growth stunting where meat affordability is limited.
  • Increased meat intake in low-income settings is linked to improved IQ and school performance.
  • The Eat-Lancet “planetary health” diet is at the expense of human health; the CO2 premise is wrong.

• Vegetable oils and environment/light exposure

  • Vegetable oil avoidance is recommended.
  • Diabetes reversal without avoiding vegetable oils is “proven” by the CSRO.
  • Vegetable oils start the process and take ~20 years to damage metabolism; carbohydrate avoidance largely fixes downstream effects.
  • Vegetable oil half-life is ~400 days; ~5 years is needed to meaningfully reduce levels; 5-year trials are needed for long-term metabolic outcomes.
  • LED lighting removes infrared; infrared supports mitochondrial function; infrared on the back lowers blood sugar.

• Lipids, risk markers, and statin use

  • LDL sometimes increases on low-carbohydrate diets; overall risk factors decrease.
  • High HDL makes LDL cholesterol less clinically important.
  • Triglyceride/HDL ratio is a risk predictor; statin benefit is absent with good triglyceride/HDL ratio or negative CAC.
  • Statin deprescribing occurs when it appears safe.

• Practical counseling heuristics

  • Routine diet questioning is used for patients with and without procedures.
  • Self-reported “healthy diet” is a red flag for high-compliance patients with ongoing metabolic harm from standard dietary guidance.
  • Alcohol guidance is keeping carbohydrates low and swapping carbohydrates for alcohol when abstinence is unlikely.

PAPERS/REPORTS NAMED

• [00:07] EAT–Lancet Commission “planetary health diet” report:
  • Willett W, et al. Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems (2019).
  • DOI: 10.1016/S0140-6736(18)31788-4

STUDIES DESCRIBED

• [00:11] Two-week <30 g/day carbohydrate intervention in ten fatty-liver patients with microbiome/folate changes (resolved from descriptor; search key: ten subjects NAFLD 14 days <30 g carbohydrates folate gut microbiota):
  • Mardinoglu A, et al. An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. Cell Metabolism (2018).
  • DOI: 10.1016/j.cmet.2018.01.005
• [00:06] Red/infrared light on back reducing blood glucose (candidate resolution from descriptor; search key: 670 nm light on back reduces blood glucose human glucose tolerance test):
  • Powner MB, Jeffery G. Light stimulation of mitochondria reduces blood glucose levels. Journal of Biophotonics (2024).
  • DOI: 10.1002/jbio.202300521

:::